Clinical impact of first‐line PD‐1 or PD‐L1 inhibitors combined with chemotherapy in extensive‐stage small cell lung cancer patients: A real‐world multicenter propensity score‐matc... by Jingyuan Xie, Mo Chen, Hedong Han, Ke Xu, Guihuan Qiu, Xinqing Lin, Yong Song, Jinjun Ye, Tangfeng Lv, Ping Zhan

Get full text

Biological and clinical characteristics of non-small cell lung cancer non-specific subtype by Xiaohong Xie, Chen Zeng, Fei Wang, Guihuan Qiu, Ziyao Chen, Ting Liu, Xinqing Lin, Zhanhong Xie, Yinyin Qin, Yansheng Wang, Xiaodong Ma, Ming Liu, Chengzhi Zhou

Get full text

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial by Ming Liu, Guihuan Qiu, Wenhui Guan, Xiaohong Xie, Xinqing Lin, Zhanhong Xie, Jiexia Zhang, Yinyin Qin, Haijian Du, Xin Chen, Yu Deng, Shiyue Li, Nanshan Zhong, Chengzhi Zhou

Get full text

A retrospective real‐world experience of immunotherapy in patients with extensive stage small‐cell lung cancer by Guihuan Qiu, Fei Wang, Xiaohong Xie, Ting Liu, Chen Zeng, Ziyao Chen, Maolin Zhou, Haiyi Deng, Yilin Yang, Xinqing Lin, Zhanhong Xie, Gengyun Sun, Chengzhi Zhou, Ming Liu

Get full text